Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinuation.
Eron JJ Jr, Bartlett JA, Santana JL, Bellos NC, Johnson J, Keller A, Kuritzkes DR, St Clair MH, Johnson VA. Eron JJ Jr, et al. Among authors: keller a. J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1581-3. doi: 10.1097/00126334-200412150-00009. J Acquir Immune Defic Syndr. 2004. PMID: 15577413 Clinical Trial.
A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.
McKinney RE Jr, Johnson GM, Stanley K, Yong FH, Keller A, O'Donnell KJ, Brouwers P, Mitchell WG, Yogev R, Wara DW, Wiznia A, Mofenson L, McNamara J, Spector SA. McKinney RE Jr, et al. Among authors: keller a. J Pediatr. 1998 Oct;133(4):500-8. doi: 10.1016/s0022-3476(98)70057-5. J Pediatr. 1998. PMID: 9787687 Clinical Trial.
Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group.
Lewis LL, Venzon D, Church J, Farley M, Wheeler S, Keller A, Rubin M, Yuen G, Mueller B, Sloas M, Wood L, Balis F, Shearer GM, Brouwers P, Goldsmith J, Pizzo PA. Lewis LL, et al. Among authors: keller a. J Infect Dis. 1996 Jul;174(1):16-25. doi: 10.1093/infdis/174.1.16. J Infect Dis. 1996. PMID: 8655986 Clinical Trial.
Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy.
McCoig C, Castrejón MM, Castaño E, De Suman O, Báez C, Redondo W, McClernon D, Danehower S, Lanier ER, Richardson C, Keller A, Hetherington S, Sáez-Llorens X, Ramilo O. McCoig C, et al. Among authors: keller a. J Pediatr. 2002 Jul;141(1):36-44. doi: 10.1067/mpd.2002.125007. J Pediatr. 2002. PMID: 12091849 Clinical Trial.
Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected children.
Mueller BU, Lewis LL, Yuen GJ, Farley M, Keller A, Church JA, Goldsmith JC, Venzon DJ, Rubin M, Pizzo PA, Balis FM. Mueller BU, et al. Among authors: keller a. Antimicrob Agents Chemother. 1998 Dec;42(12):3187-92. doi: 10.1128/AAC.42.12.3187. Antimicrob Agents Chemother. 1998. PMID: 9835513 Free PMC article. Clinical Trial.
2,520 results